Tedizolid Prolonged Treatment for Prosthetic Joint Infections
Status:
Completed
Trial end date:
2021-08-22
Target enrollment:
Participant gender:
Summary
Pilot study the aim of which is to obtain reliable data on the tolerance, compliance and
efficacy of Tedizolid used as prolonged (≥ 6 weeks) monotherapy or in combination therapy for
the treatment of patients with orthopedic device infections due to Gram positive cocci.